Assay-Specific Spurious ACTH Results Lead to Misdiagnosis, Unnecessary Testing, and Surgical Misadventure—A Case Series
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The proper clinical evaluation of pituitary and adrenal disorders depends on the accurate measurement of plasma ACTH. The modern two-site sandwich ACTH immunoassay is a great improvement compared with older methods but still has the potential for interferences such as heterophile antibodies and pro-opiomelanocortin (POMC) and ACTH fragments. We report the cases of five patients in whom the diagnosis or differential diagnosis of Cushing syndrome was confounded by erroneously elevated results from the Siemens ACTH Immulite assay [ACTH(Immulite)] that were resolved using the Roche Cobas or Tosoh AIA [ACTH(Cobas) and ACTH(AIA), respectively]. In one case, falsely elevated ACTH(Immulite) results owing to interfering antibodies resulted in several invasive differential diagnostic procedures (including inferior petrosal sinus sampling), MRI, and unnecessary pituitary surgery. ACTH(Cobas) measurements were normal, and further studies excluded the diagnosis of Cushing syndrome. In three cases, either Cushing disease or occult ectopic ACTH were suspected owing to elevated ACTH(Immulite) results. However, adrenal (ACTH-independent) Cushing syndrome was established using ACTH(AIA) or ACTH(Cobas) and proved surgically. In one case, ectopic ACTH was suspected owing to elevated ACTH(Immulite) results; however, the ACTH(Cobas) findings led to the diagnosis of alcohol-induced hypercortisolism that resolved with abstinence. We have concluded that ACTH(Immulite) results can be falsely increased and alternate ACTH assays should be used in the diagnosis or differential diagnosis of clinical disorders of the hypothalamic-pituitary-adrenal axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A physiologic approach to diagnosis of the Cushing syndrome.
Raff, H., & Findling, J. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-12-200306170-00010 · Cited by 186 · cited 1×
“This illustrates the important rule that IPSS should never be performed unless the diagnosis of ACTH-dependent Cushing syndrome is certain because normal subjects can have ACTH responses to CRH and ACTH IPS/P ratios that overlap with those of patients with Cushing disease [26, 27].”
Self-citationRaff, H., Sharma, S. T., & Nieman, L. K. (2014) · Comprehensive Physiology · doi:10.1002/cphy.c130035 · Cited by 141 · cited 1×
“The accurate measurement of plasma ACTH is necessary for the proper diagnosis, differential diagnosis, and monitoring of hypothalamic–pituitary–adrenal axis disorders, including Cushing syndrome, adrenal insufficiency, and congenital adrenal hyperplasia [1].”
BackgroundSelf-citationFindling, J. W., & Raff, H. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0946 · Cited by 134 · cited 1×
“14)], confirming the diagnosis of alcoholinduced hypercortisolism [24].”
Self-citationRAFF, H., FINDLING, J. W., & WONG, J. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-678 · Cited by 26
Self-citation
Research works printed but not linked: 24
- Findling, 1990, The use of immunoradiometric assay for the measurement of ACTH in human plasma, Trends Endocrinol Metab, 1, 283, 10.1016/1043-2760(90)90064-A · DOI
- Lindsay, 2006, A comparison of immunometric and radioimmunoassay measurement of ACTH for the differential diagnosis of Cushing’s syndrome, J Endocrinol Invest, 29, 983, 10.1007/BF03349211 · DOI
- Talbot, 2003, Analytical and clinical aspects of adrenocorticotrophin determination, Ann Clin Biochem, 40, 453, 10.1258/000456303322326371 · DOI · Paper page
- Raff, 1989, A new immunoradiometric assay for corticotropin evaluated in normal subjects and patients with Cushing’s syndrome, Clin Chem, 35, 596, 10.1093/clinchem/35.4.596 · DOI · Paper page
- Bolstad, 2012, A man with abdominal pain: enough evidence for surgery, Clin Chem, 58, 1187, 10.1373/clinchem.2011.167015 · DOI
- Bolstad, 2013, Heterophilic antibody interference in immunometric assays, Best Pract Res Clin Endocrinol Metab, 27, 647, 10.1016/j.beem.2013.05.011 · DOI · Paper page
- Grasko, 2013, A diagnostic conundrum: heterophilic antibody interference in an adrenocorticotropic hormone immunoassay not detectable using a proprietary heterophile blocking reagent, Ann Clin Biochem, 50, 433, 10.1177/0004563213487514 · doi:10.1177/0004563213487514
- Choy, 2017, Immunoassay interference complicating management of Cushing’s disease: the onus is on the clinician and the laboratory, Ann Clin Biochem, 54, 183, 10.1177/0004563216657362 · DOI
- Donegan, 2019, Corticotropin hormone assay interference: a case series, Clin Biochem, 63, 143, 10.1016/j.clinbiochem.2018.11.006 · DOI
- Smith, 2002, Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays, J Clin Endocrinol Metab, 87, 5410, 10.1210/jc.2001-011943 · DOI · Paper page
- Page-Wilson, 2014, Clinical utility of plasma POMC and AgRP measurements in the differential diagnosis of ACTH-dependent Cushing’s syndrome, J Clin Endocrinol Metab, 99, E1838, 10.1210/jc.2014-1448 · DOI
- Findling, 1991, Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing’s syndrome: early recognition of the occult ectopic ACTH syndrome, J Clin Endocrinol Metab, 73, 408, 10.1210/jcem-73-2-408 · DOI · Paper page
- Findling, 2004, Identification of patients with Cushing’s disease with negative pituitary adrenocorticotropin gradients during inferior petrosal sinus sampling: prolactin as an index of pituitary venous effluent, J Clin Endocrinol Metab, 89, 6005, 10.1210/jc.2004-1378 · DOI · Paper page
- Doppman, 1998, Bilateral sampling of the internal jugular vein to distinguish between mechanisms of adrenocorticotropic hormone-dependent Cushing syndrome, Ann Intern Med, 128, 33, 10.7326/0003-4819-128-1-199801010-00006 · DOI · Paper page
- Ilias, 2004, Jugular venous sampling: an alternative to petrosal sinus sampling for the diagnostic evaluation of adrenocorticotropic hormone-dependent Cushing’s syndrome, J Clin Endocrinol Metab, 89, 3795, 10.1210/jc.2003-032014 · DOI · Paper page
- Radvany, 2016, Venous sampling for Cushing disease: comparison of internal jugular vein and inferior petrosal sinus sampling, Endocr Pract, 22, 1057, 10.4158/EP161266.OR · DOI
- Hayes, 2018, The ectopic adrenocorticotropic hormone syndrome: rarely easy, always challenging, Endocrinol Metab Clin North Am, 47, 409, 10.1016/j.ecl.2018.01.005 · DOI · Paper page
- Wand, 1991, Alterations in the hypothalamic-pituitary-adrenal axis in actively drinking alcoholics, J Clin Endocrinol Metab, 72, 1290, 10.1210/jcem-72-6-1290 · DOI · Paper page
- Oldfield, 1991, Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome, N Engl J Med, 325, 897, 10.1056/NEJM199109263251301 · DOI · Paper page
- Yanovski, 1993, The limited ability of inferior petrosal sinus sampling with corticotropin-releasing hormone to distinguish Cushing’s disease from pseudo-Cushing states or normal physiology, J Clin Endocrinol Metab, 77, 503
- Sturgeon, 2011, Analytical error and interference in immunoassay: minimizing risk, Ann Clin Biochem, 48, 418, 10.1258/acb.2011.011073 · DOI · Paper page
- Samarasinghe, 2017, Biotin interference with routine clinical immunoassays: understand the causes and mitigate the risks, Endocr Pract, 23, 989, 10.4158/EP171761.RA · DOI
- Dennedy, 2017, Low DHEAS: a sensitive and specific test for the detection of subclinical hypercortisolism in adrenal incidentalomas, J Clin Endocrinol Metab, 102, 786
- Aron, 1997, Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome, J Clin Endocrinol Metab, 82, 1780
Cited by
Javorsky, B. R., Raff, H., Carroll, T. B., Algeciras-Schimnich, A., Singh, R. J., Colón-Franco, J. M., & Findling, J. W. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab022 · Cited by 171
“Plasma ACTH was measured using the Roche Cobas platform immunometric assay [31, 32].”
MethodSelf-citationKiseljak-Vassiliades, K., Bancos, I., Hamrahian, A., Habra, M. A., Vaidya, A., Levine, A. C., & Else, T. (2020) · Endocrine Practice · doi:10.4158/dscr-2020-0567 · Cited by 66
“While an undetectable ACTH level would be expected in patients with autonomous glucocorticoid secretion, it is important to note that in most of the current clinically available assays, ACTH level might not be entirely suppressed even with overt ACTH-independent Cushing syndrome (14).”
BackgroundHypercortisolemia Recurrence in Cushing’s disease; a diagnostic challenge
Hinojosa-Amaya, J. M., Varlamov, E. V., McCartney, S., & Fleseriu, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00740 · Cited by 45
Molecular Derangements and the Diagnosis of ACTH-Dependent Cushing’s Syndrome
Nieman, L. K. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab046 · Cited by 33
Does concomitant prolactin measurement ıncrease the accuracy of ınferior petrosal sinus sampling?
Apaydin, T., Yasar, M., Baltacioglu, F., Haklar, G., & Gogas Yavuz, D. (2022) · Neuroradiology · doi:10.1007/s00234-021-02886-6 · Cited by 6
“Lastly, it has been previously reported that ACTH assay interference might result in falsely elevated ACTH concentrations using the Siemens Immulite assay [34, 35].”
Method
Metadata
- Authors
- Greene, L. W., Geer, E. B., Page-Wilson, G., Findling, J. W., & Raff, H.
- Venue
- Journal of the Endocrine Society
- Publisher
- The Endocrine Society
- Published
- 2019-02-20
- Volume
- 3
- Issue
- 4
- Pages
- 763-772
- ISSN
- 2472-1972 (ISSN-L)
- OpenAlex
- W2916587682
- Cited by
- 49
- References
- 4
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- Robert Wood Johnson Foundation (71951)
- Aurora Research Institute
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assay-Specific Spurious ACTH Results Lead to Misdiagnosis, Unnecessary Testing, and Surgical Misadventure—A Case Series. https://app.cochat.ai/papers/10.1210/js.2019-00027
- The paper
- Greene, L. W., Geer, E. B., Page-Wilson, G., Findling, J. W., & Raff, H. (2019). Assay-Specific Spurious ACTH Results Lead to Misdiagnosis, Unnecessary Testing, and Surgical Misadventure—A Case Series. Journal of the Endocrine Society. https://doi.org/10.1210/js.2019-00027
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.